At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
goLITE +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder
In Brief
A clinical study evaluating goLITE and Control for Seasonal Affective Disorder. Completed, enrolled 35 participants across 4 sites.
Detailed Summary
The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeasonal Affective Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 2011
Enrollment StartJan 2012
Primary CompletionApr 2012
TodayJul 2026
First PostedOct 31, 2011
Enrollment StartJan 6, 2012
Primary CompletionApr 2, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.7 years ago
Interventions
goLITEdevice
goLITE at 30 minutes per day, within 30 minutes of waking in the morning
Controldevice
light therapy using 580nm LED source within 30 minutes of waking in the morning every day for 6 weeks